Middle East Healthcare Company (Saudi German Health) Announces the Board of Directors’ Recommendation to Distribute Cash Dividends to Shareholders for the Fiscal Year Ending on December 31, 2024

24 March 2025

Introduction	Introduction Middle East Healthcare Company (Saudi German Health) announces the recommendation of its Board of Directors, issued on March 24, 2025, to distribute cash dividends to the company’s shareholders for the fiscal year ending on December 31, 2024
Date of the board’s recommendation	2025-03-24 Corresponding to 1446-09-24
The Total amount distributed	SAR 46,020,000
Number of Shares Eligible for Dividends	92,040,000 shares
Dividend per share	SAR 0.50
Percentage of Dividend to the Share Par Value (%)	5
Eligibility date	The eligibility of dividends shall be for shareholders who own the company’s shares at the end of the day of the Ordinary General Assembly meeting and who are registered in the company’s shareholders register at the Securities Depository Center (Edaa) by the end of the second trading day following the date of the Assembly meeting.
Distribution Date	The distribution date will be announced later, following the approval of the Ordinary General Assembly.
The name of other official authorities and the details of their non-refusal to the recommendation or decision	N/A
Additional Information	The company will announce the date of the Ordinary General Assembly meeting upon obtaining the necessary regulatory approvals. The distribution will be made through direct transfer to the bank accounts linked to the shareholders' investment portfolios. We would also like to draw the attention of non-resident foreign investors that cash dividends transferred through the resident financial intermediary are subject to a 5% withholding tax upon transfer or credit to their account, in accordance with Article (68) of the Tax Law and Article (63) of its Implementing Regulations. The company urges shareholders to update their information and ensure their bank account numbers are correctly linked to their investment portfolios to ensure timely receipt of their dividends without delay. We are pleased to receive your inquiries through the Investor Relations Department via the following contact channels: Email: [email protected]